Report Detail
Global Irritable Bowel Syndrome (IBS) Market Growth 2019-2024
- RnM2847901 |
- 31 January, 2019 |
- Global |
- 139 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
Currently, the IBS treatment market is naïve and underpenetrated, with 4 products indicated for IBS in the market. These include the IBS-C therapies, Amitiza (lubiprostone, Sucampo/Takeda) and Linzess (linaclotide, Ironwood/Allergan/Astellas); and the IBS-D therapies, Lotronex (Sebela Pharmaceuticals) and Irribow (ramosetron, Astellas). Antidepressants and antibiotics (mainly Xifaxan [rifaximin], Valeant) are also used off-label to treat IBS.
The IBS treatment market is characterized by significant unmet needs, which include the need for products with improved efficacy, products for the treatment of the IBS-D and IBS-M subtypes, and products that effectively address IBS symptoms, such as abdominal pain and bloating, as well as the requirement for the improved diagnosis of IBS. As a result, there are significant opportunities in the uncrowded IBS therapeutics market.
According to this study, over the next five years the Irritable Bowel Syndrome (IBS) market will register a 16.3% CAGR in terms of revenue, the global market size will reach US$ 6530 million by 2024, from US$ 2640 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Irritable Bowel Syndrome (IBS) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Irritable Bowel Syndrome (IBS) market by product type, application, key manufacturers and key regions and countries.
This study considers the Irritable Bowel Syndrome (IBS) value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
IBS-D Drug
IBS-C Drug
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Women
Men
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Allergan
Valeant Pharmaceuticals
Takeda
Sucampo Pharmaceuticals
McNeil Consumer Healthcare
Sebela Pharmaceuticals
Astellas Pharmaceuticals
IM HealthScience
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Irritable Bowel Syndrome (IBS) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Irritable Bowel Syndrome (IBS) market by identifying its various subsegments.
Focuses on the key global Irritable Bowel Syndrome (IBS) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Irritable Bowel Syndrome (IBS) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Irritable Bowel Syndrome (IBS) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Irritable Bowel Syndrome (IBS) Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Irritable Bowel Syndrome (IBS) Consumption 2014-2024
- 2.1.2 Irritable Bowel Syndrome (IBS) Consumption CAGR by Region
- 2.2 Irritable Bowel Syndrome (IBS) Segment by Type
- 2.2.1 IBS-D Drug
- 2.2.2 IBS-C Drug
- 2.2.3 Other
- 2.3 Irritable Bowel Syndrome (IBS) Consumption by Type
- 2.3.1 Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Type (2014-2019)
- 2.4 Irritable Bowel Syndrome (IBS) Segment by Application
- 2.4.1 Women
- 2.4.2 Men
- 2.5 Irritable Bowel Syndrome (IBS) Consumption by Application
- 2.5.1 Global Irritable Bowel Syndrome (IBS) Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Irritable Bowel Syndrome (IBS) Value and Market Share by Application (2014-2019)
- 2.5.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Application (2014-2019)
3 Global Irritable Bowel Syndrome (IBS) by Players
- 3.1 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Players
- 3.1.1 Global Irritable Bowel Syndrome (IBS) Sales by Players (2017-2019)
- 3.1.2 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Players (2017-2019)
- 3.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players
- 3.2.1 Global Irritable Bowel Syndrome (IBS) Revenue by Players (2017-2019)
- 3.2.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2017-2019)
- 3.3 Global Irritable Bowel Syndrome (IBS) Sale Price by Players
- 3.4 Global Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Irritable Bowel Syndrome (IBS) Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Irritable Bowel Syndrome (IBS) by Regions
- 4.1 Irritable Bowel Syndrome (IBS) by Regions
- 4.1.1 Global Irritable Bowel Syndrome (IBS) Consumption by Regions
- 4.1.2 Global Irritable Bowel Syndrome (IBS) Value by Regions
- 4.2 Americas Irritable Bowel Syndrome (IBS) Consumption Growth
- 4.3 APAC Irritable Bowel Syndrome (IBS) Consumption Growth
- 4.4 Europe Irritable Bowel Syndrome (IBS) Consumption Growth
- 4.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption Growth
5 Americas
- 5.1 Americas Irritable Bowel Syndrome (IBS) Consumption by Countries
- 5.1.1 Americas Irritable Bowel Syndrome (IBS) Consumption by Countries (2014-2019)
- 5.1.2 Americas Irritable Bowel Syndrome (IBS) Value by Countries (2014-2019)
- 5.2 Americas Irritable Bowel Syndrome (IBS) Consumption by Type
- 5.3 Americas Irritable Bowel Syndrome (IBS) Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Irritable Bowel Syndrome (IBS) Consumption by Countries
- 6.1.1 APAC Irritable Bowel Syndrome (IBS) Consumption by Countries (2014-2019)
- 6.1.2 APAC Irritable Bowel Syndrome (IBS) Value by Countries (2014-2019)
- 6.2 APAC Irritable Bowel Syndrome (IBS) Consumption by Type
- 6.3 APAC Irritable Bowel Syndrome (IBS) Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Irritable Bowel Syndrome (IBS) by Countries
- 7.1.1 Europe Irritable Bowel Syndrome (IBS) Consumption by Countries (2014-2019)
- 7.1.2 Europe Irritable Bowel Syndrome (IBS) Value by Countries (2014-2019)
- 7.2 Europe Irritable Bowel Syndrome (IBS) Consumption by Type
- 7.3 Europe Irritable Bowel Syndrome (IBS) Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Irritable Bowel Syndrome (IBS) by Countries
- 8.1.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Value by Countries (2014-2019)
- 8.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Type
- 8.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Irritable Bowel Syndrome (IBS) Distributors
- 10.3 Irritable Bowel Syndrome (IBS) Customer
11 Global Irritable Bowel Syndrome (IBS) Market Forecast
- 11.1 Global Irritable Bowel Syndrome (IBS) Consumption Forecast (2019-2024)
- 11.2 Global Irritable Bowel Syndrome (IBS) Forecast by Regions
- 11.2.1 Global Irritable Bowel Syndrome (IBS) Forecast by Regions (2019-2024)
- 11.2.2 Global Irritable Bowel Syndrome (IBS) Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Irritable Bowel Syndrome (IBS) Forecast by Type
- 11.8 Global Irritable Bowel Syndrome (IBS) Forecast by Application
12 Key Players Analysis
- 12.1 Allergan
- 12.1.1 Company Details
- 12.1.2 Irritable Bowel Syndrome (IBS) Product Offered
- 12.1.3 Allergan Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Allergan News
- 12.2 Valeant Pharmaceuticals
- 12.2.1 Company Details
- 12.2.2 Irritable Bowel Syndrome (IBS) Product Offered
- 12.2.3 Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Valeant Pharmaceuticals News
- 12.3 Takeda
- 12.3.1 Company Details
- 12.3.2 Irritable Bowel Syndrome (IBS) Product Offered
- 12.3.3 Takeda Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Takeda News
- 12.4 Sucampo Pharmaceuticals
- 12.4.1 Company Details
- 12.4.2 Irritable Bowel Syndrome (IBS) Product Offered
- 12.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Sucampo Pharmaceuticals News
- 12.5 McNeil Consumer Healthcare
- 12.5.1 Company Details
- 12.5.2 Irritable Bowel Syndrome (IBS) Product Offered
- 12.5.3 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 McNeil Consumer Healthcare News
- 12.6 Sebela Pharmaceuticals
- 12.6.1 Company Details
- 12.6.2 Irritable Bowel Syndrome (IBS) Product Offered
- 12.6.3 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Sebela Pharmaceuticals News
- 12.7 Astellas Pharmaceuticals
- 12.7.1 Company Details
- 12.7.2 Irritable Bowel Syndrome (IBS) Product Offered
- 12.7.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Astellas Pharmaceuticals News
- 12.8 IM HealthScience
- 12.8.1 Company Details
- 12.8.2 Irritable Bowel Syndrome (IBS) Product Offered
- 12.8.3 IM HealthScience Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 IM HealthScience News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Irritable Bowel Syndrome (IBS) . Industry analysis & Market Report on Irritable Bowel Syndrome (IBS) is a syndicated market report, published as Global Irritable Bowel Syndrome (IBS) Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Irritable Bowel Syndrome (IBS) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
